Related Experiment Video
Updated: Feb 15, 2026

Studying Wnt Signaling During Patterning of Conducting Airways
Published on: October 16, 2016
Chemical Modulation of WNT Signaling in Cancer
1University of Texas Southwestern Medical Center, Dallas, TX, United States.
Abstract:
Genetically based observations stemming from defects in development and in regeneration form the foundation of our understanding regarding how the secreted WNT proteins control coordinated cell fate decision-making in adult tissues. At the same time, our anticipation of potential benefits and unwanted toxicities associated with candidate anticancer agents targeting WNT signal transduction are also reliant upon this blueprint of WNT-associated physiology. Despite the long established role of WNT signaling in cancer, the emergence of WNT signaling as a suppressor of immunological attack in melanoma reveals an unanticipated anticancer potential in targeting WNT signaling. Here we review the literature associated with WNT signaling in cancer and discuss potential challenges that may be associated with the chemical attack of this important cellular process in achieving therapeutic goals. Although a number of small molecules targeting WNT signaling are introduced here, we center our discussion on antagonists of the WNT acyltransferase porcupine (PORCN) given the recent entry of two candidate molecules in clinical testing.
Insights
WNT signaling, crucial for cell fate, also suppresses immune responses in melanoma. Targeting WNT, particularly PORCN, offers novel anticancer strategies despite potential challenges.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Background:
- WNT proteins are key regulators of cell fate decisions in development and tissue regeneration.
- Understanding WNT signaling is vital for predicting efficacy and toxicity of anticancer drugs.
- WNT signaling's role in cancer is long-established, but its function in suppressing immune attack in melanoma is a recent discovery.
Purpose of the Study:
- To review the literature on WNT signaling in cancer.
- To discuss the potential of targeting WNT signaling as an anticancer strategy, especially in melanoma.
- To explore challenges associated with targeting WNT signaling therapeutically.
Main Methods:
- Literature review of WNT signaling in cancer.
- Focus on small molecules targeting WNT signaling, particularly PORCN antagonists.
- Discussion of clinical trial data for PORCN inhibitors.
Main Results:
- WNT signaling plays a dual role in cancer, acting as both an oncogene and an immune suppressor.
- Targeting WNT signaling, especially its role in immune suppression in melanoma, presents a novel therapeutic avenue.
- PORCN antagonists show promise, with two candidates currently in clinical trials.
Conclusions:
- WNT signaling's complex role in cancer necessitates careful therapeutic targeting.
- Inhibiting WNT signaling, particularly through PORCN antagonists, offers a promising strategy against melanoma by potentially enhancing anti-tumor immunity.
- Further research and clinical evaluation are needed to overcome challenges in WNT-targeted cancer therapy.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Bacterial Signaling
Chemical Formulas

